The London Biotechnology Show returns for its highly anticipated second edition, building on the remarkable success of its ...

Prime Medicine, known for its goal of treating hundreds of diseases with CRISPR, says it's narrowing its focus to two. It ...

A Massachusetts-based wound care and sports medicine company announced plans for its brand-new biomanufacturing facility ...

The discovery of recombinant DNA proved that biology, not chemistry alone, could create new medicines like life-saving ...

Prime Medicine is eliminating 25% of its workforce in a restructuring that includes the company pivoting its prime ...

In the Phase 2 study of patients with chronic kidney disease, the highest dose of the drug lowered by 86% the levels of ...

Healthcare Patent Filing Outsourcing Market, revealing compelling growth prospects over the next decade. According to the ...

In a world increasingly reliant on biologics and precision medicine, it’s clear that advanced cold storage is not just a ...

Contrarian investing advice from biotech and pharmaceutical stock expert Hartaj Singh, Founding Partner of Tecumseh Partners ...

Durham-based Atsena Therapeutics has received Regenerative Medicine Advanced Therapy (RMAT) designation from the U.S. Food and Drug Administration (FDA) for ATSN-201, its gene therapy product for the ...

PDS Biotechnology Corporation (NASDAQ: PDSB) Q1 2025 Earnings Call Transcript May 14, 2025 PDS Biotechnology Corporation ...